Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Genetic Insights Into Primary Restrictive Cardiomyopathy

Version 1 : Received: 17 March 2022 / Approved: 18 March 2022 / Online: 18 March 2022 (09:05:21 CET)

A peer-reviewed article of this Preprint also exists.

Brodehl, A.; Gerull, B. Genetic Insights into Primary Restrictive Cardiomyopathy. J. Clin. Med. 2022, 11, 2094. Brodehl, A.; Gerull, B. Genetic Insights into Primary Restrictive Cardiomyopathy. J. Clin. Med. 2022, 11, 2094.

Abstract

Restrictive cardiomyopathy is a rare cardiac disease causing severe diastolic dysfunction, ventricular stiffness and dilated atria. In consequence, it induces heart failure often with preserved ejection fraction and is associated with a high mortality. Since a poor clinical prognosis, patients with restrictive cardiomyopathy require frequently heart transplantation. Genetic as well as non-genetic factors contribute to restrictive cardiomyopathy and a significant portion of cases remains of unknown etiology. However, the genetic forms of restrictive cardiomyopathy and the involved molecular pathomechanisms are only partially understood. In this review, we summarize the current knowledge about primary genetic restrictive cardiomyopathy and describe its genetic landscape, which might be of interest for geneticists as well as for cardiologists.

Keywords

Restrictive Cardiomyopathy; Cardiomyopathy; Cardiovascular Genetics; Desmin; Troponin; Filamin-C

Subject

Medicine and Pharmacology, Cardiac and Cardiovascular Systems

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.